

Cover Story
By Matthew Bin Han Ong
In his first talk to NCI staff, director Norman “Ned” Sharpless presented himself as an institute insider—highlighting his career-long relationships with NCI and its “legends,” demonstrating his grasp of the institute's agenda and research portfolio.
In Brief


Drugs & Targets
Trending Stories
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - Trump et al. focus on NIH, cancer—and how peer review is done
- Bhattacharya provides calm answers to anxious questions at confirmation hearing
Trump nominee for NIH director calls for transparency, audits of indirect costs - Biden’s FY23 proposal cuts NCI funds by $199M, while boosting ARPA-H by $4B
- Harnessing innovation: The next frontier in surgical oncology
- In the Headlines: What are Jay Bhattacharya’s plans for NIH?